Cefepime
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5451 publications
Clinical and microbiological characteristics of viridans group streptococcal bacteremia in pediatric and adolescent patients with cancer.
Journal: Pediatric hematology and oncology
Published: June 23, 2026
An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant gram-negative pathogens.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 19, 2026
Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: June 15, 2026
The impact of vancomycin and piperacillin-tazobactam combination therapy on the incidence of acute kidney injury: a retrospective review.
Journal: Proceedings (Baylor University. Medical Center)
Published: June 10, 2026
Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: June 09, 2026
Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling.
Journal: Antimicrobial agents and chemotherapy
Published: June 04, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: May 29, 2026
Corynebacterium amycolatum: An Emerging Pathogen in Chronic Otitis Media.
Journal: Cureus
Published: May 21, 2026
Potential Pharmacogenomics (PGx), Human Leukocyte Antigen (HLA) Antiviral to Cephalosporin Crossover Reaction.
Journal: Journal of pharmacy practice
Published: May 06, 2026
Overview of novel cefepime-based β-lactam/β-lactamase inhibitor combinations.
Journal: Expert review of anti-infective therapy
Published: May 05, 2026
Combating antimicrobial resistance in ESBL- and AmpC-producing Enterobacterales: In vitro evaluation of cefepime-enmetazobactam.
Journal: Indian journal of medical microbiology
Published: May 01, 2026
Enterococcus faecalis alters antibiotic susceptibility in Pseudomonas aeruginosa mixed-species biofilms.
Journal: Journal of bacteriology
Published: April 30, 2026
Last Updated: 06/30/2026